Financial News

PPD’s 3Q Revenues up 27%

Clinical Development Services revenue up 26% and Laboratory Services revenue grew 29%.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PPD 3Q Revenues: $1.6 billion (+27%) 3Q Earnings: $169.0 million (earnings were $9.1 million 3Q20) YTD Revenues: $4.5 billion (+36%) YTD Earnings: $268.0 million (earnings were $58.1 million YTD20) Comments: Net authorizations growth of 12.7% over third quarter 2020 to $1.4 billion, resulting in a net book-to-bill ratio of 1.19x on a historical basis Ending backlog growth of 20.3% over third quarter 2020 to $9.5 billion on a historical basis. Revenue for the quarter increased 26.5% to $1.6 ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters